Skip to content
Research Article Open access CC BY 4.0

The Ameliorative Effect of Ashwagandha- Withania somnifera (L.) Dunal on park25 Induced Neurodegeneration in Drosophila melanogaster Parkinson’s Disease Model

Mamatha Nagamadhu Murthy, V. Chandana, H. D. Nisarga, Baragur Venkatanarayanasetty Shyamala

European Journal of Medicinal Plants · pp. 1–12 · Published 27 Jun 2023

10.9734/ejmp/2023/v34i61140

Abstract

Ashwagandha - Withania somnifera (L.) Dunal is a perennial shrub belonging to the family Solanaceae. Ashwagandha has been used for over 3000 years in traditional Indian Ayurveda for treatment of various neurological, and stress disorders. The root of Ashwagandha (ASH) is regarded as a tonic, aphrodisiac, narcotic, diuretic, anthelmintic, astringent, thermogenic and stimulant. Ashwagandha with other herbal decoctions was recognized to treat Kampavatha (Parkinson’s Disease) since 18th century. With this wide array of ethnopharmacological relevance, Ashwagandha has been recognized as one of the prominent complementary and alternative medicine to treat many neurodegenerative diseases like Alzheimer’s (AD) and Parkinson’s disease (PD). There is a prominent increase in the cases of AD and PD all over the world and it demands the requirement of complementary and alternative herbal remedies with no/minimal side effects. Many genetic factors are responsible for the onset and progression of PD. Loss-of-function mutations in the parkin gene are a major cause of early onset of autosomal recessive juvenile parkinsonism (AR-JP). Drosophila park25 loss of function mutants exhibit significantly increased number of mitochondria-endoplasmic reticulum contacts and a significantly decreased number of dopaminergic neurons in the adult brain which is the main cause of PD condition. Several studies have demonstrated the ability of Ashwagandha in imparting neuroprotection, improved locomotory ability, memory and learning abilities. The challenge lies in scrutinizing the mechanism and the pathways involved in the neuroprotective properties of this well-known herb. Here in our study, we test the possible neuroprotective effect of Ashwagandha on park25 mutants of Drosophila using lifespan analysis and climbing disability as a disease marker. Parkinson’s mimicking flies were administered with aqueous extraction of Ashwagandha-root mixed with the fly food and subjected to negative geotaxis assay. We observed that there is a prominent increase in the climbing ability in park25 treated flies compared to its age-matched untreated flies. This is the first report showing that, aqueous extraction of Ashwagandha-root extract was able to ameliorate the disease phenotype in the park25 Drosophila Parkinson’s disease model.

Ashwagandha / Withania somnifera neurodegeneration Parkinson’s disease Drosophila disease model park25 motor dysfunction lifespan

References (38)

  1. 1 Parkin is recruited selectively to impaired mitochondria and promotes their autophagy [DOI]
  2. 2 PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 [DOI]
  3. 3 A Drosophila model of Parkinson's disease [DOI]
  4. 4 Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase [DOI]
  5. 5 PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy [DOI]
  6. 6 Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin [DOI]
  7. 7 Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin [DOI]
  8. 8 Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 [DOI]
  9. 9 Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.
  10. 10 Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity [DOI]
  11. 11 Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007.
  12. 12 Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery [DOI]
  13. 13 Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin [DOI]
  14. 14 Selection on stress resistance increases longevity in Drosophila melanogaster [DOI]
  15. 15 Regulation of mitochondrial morphology and function by stearoylation of TFR1 [DOI]
  16. 16 Mitofusin-mediated ER stress triggers neurodegeneration in pink1/parkin models of Parkinson’s disease [DOI]
  17. 17 Withanolides from Withania somnifera roots [DOI]
  18. 18 Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects [DOI]
  19. 19 PINK1 Phosphorylates MIC60/Mitofilin to Control Structural Plasticity of Mitochondrial Crista Junctions [DOI]
  20. 20 Pleiotropy, Natural Selection, and the Evolution of Senescence [DOI]
  21. 21 Effects of Ashwagandha (Withania somnifera) on Physical Performance: Systematic Review and Bayesian Meta-Analysis [DOI]
  22. 22 Telomeres, DNA Damage and Ageing: Potential Leads from Ayurvedic Rasayana (Anti-Ageing) Drugs [DOI]
  23. 23 Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads from Ayurveda [DOI]
  24. 24 RETRACTED ARTICLE: Exploring the Therapeutic Effect of Neurotrophins and Neuropeptides in Neurodegenerative Diseases: at a Glance [DOI]
  25. 25 ASSOCIATION BETWEEN EARLY-ONSET PARKINSON'S DISEASE AND MUTATIONS IN THE PARKIN GENE
  26. 26 Evolutionary and Nonevolutionary Theories of Senescence [DOI]
  27. 27 Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease [DOI]
  28. 28 Production of withanolide-A from adventitious root cultures of Withania somnifera [DOI]
  29. 29 Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways [DOI]
  30. 30 Vulnerable Parkin Loss-of-Function Drosophila Dopaminergic Neurons Have Advanced Mitochondrial Aging, Mitochondrial Network Loss and Transiently Reduced Autophagosome Recruitment [DOI]
  31. 31 The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models [DOI]
  32. 32 A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics [DOI]
  33. 33 RESISTANCE TO ENVIRONMENTAL STRESS IN DROSOPHILA MELANOGASTER SELECTED FOR POSTPONED SENESCENCE [DOI]
  34. 34 Zinc supplement greatly improves the condition of parkin mutant Drosophila [DOI]
  35. 35 Label Free Fragment Screening Using Surface Plasmon Resonance as a Tool for Fragment Finding – Analyzing Parkin, a Difficult CNS Target [DOI]
  36. 36 An altered microbiome in a Parkinson’s disease model Drosophila melanogaster has a negative effect on development [DOI]
  37. 37 The Proceedings of the National Academy of Sciences [DOI]
  38. 38 Bioassay Techniques for Drug Development [DOI]

Cited by 6

Harnessing microbial factories for withaferin-a: the future of plant-based oncotherapeutics

Naimi Sirjohn, Gaurav Sharma, Duni Chand · 3 Biotech · 2025

Role and mechanism of herbal bioactives in treatment of Parkinson's disease: A promising therapeutic approach

Manpreet Kaur, Mukta Gupta · South African Journal of Botany · 2025

Showing 2 of 6 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

32

Page views

0

PDF downloads

12

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.